Sit Investment Associates’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-30,210
Closed -$3.83M 533
2021
Q3
$3.83M Hold
30,210
0.1% 228
2021
Q2
$5.02M Hold
30,210
0.12% 206
2021
Q1
$5.49M Sell
30,210
-10,590
-26% -$2.46M 0.14% 195
2020
Q4
$8.16M Sell
40,800
-3,600
-8% -$732K 0.22% 133
2020
Q3
$9.73M Buy
44,400
+7,600
+21% +$1.61M 0.29% 102
2020
Q2
$7.02M Sell
36,800
-2,100
-5% -$368K 0.22% 132
2020
Q1
$6.03M Sell
38,900
-19,100
-33% -$2.22M 0.23% 127
2019
Q4
$4.86M Hold
58,000
0.14% 184
2019
Q3
$3.93M Buy
58,000
+33,075
+133% +$2.18M 0.12% 199
2019
Q2
$1.66M Buy
+24,925
New +$1.45M 0.05% 296

Other funds holding TDOC

Sit Investment Associates's TDOC Position: Q4 2021 in Review

Sit Investment Associates sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 30,210 shares — an estimated $3.83M sold.

Sit Investment Associates first reported a position in TDOC in Q2 2019 and held it in 10 quarters. The position peaked at $9.73M in Q3 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Sit Investment Associates reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Sit Investment Associates sold 30,210 Teladoc Health shares in Q4 2021, an estimated $3.83M.
  • Sit Investment Associates first reported a position in Teladoc Health in Q2 2019 and held it in 10 quarters.
  • Sit Investment Associates's Teladoc Health position peaked at $9.73M in Q3 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Sit Investment Associates's 13F filing for Q4 2021, filed 11 Feb 2022.